Convalescent Plasma for the Treatment of Patients With WNV - a Double- Blind Randomized Controlled Study
Status:
COMPLETED
Trial end date:
2025-03-30
Target enrollment:
Participant gender:
Summary
Name of the study:
Administering neutralizing convalescent plasma to hospitalized patients with West Nile fever - a double-blind randomized controlled study.
The purpose of this study is to test the safety and effectiveness of giving blood plasma from convalescents rich in neutralizers as treatment against West Nile fever.